Search

Search Constraints

You searched for: Author/Creator Gourgou, S.

Search Results

2. 2376 Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (datecan-2): an analysis of 9 pancreatic cancer trials. (September 2015)

3. 560PImpact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trial. (18th September 2017)

4. Can the resectability of pancreatic adenocarcinoma be predicted? analysis of 1001 patients included in the national anatomo-clinical database on pancreatic adenocarcinoma (BACAP). (September 2018)

6. Early MRI predictors of disease‐free survival in locally advanced rectal cancer from the GRECCAR 4 trial. Issue 11 (22nd August 2019)

7. Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer. (October 2017)

9. OC-0498 Results of the prospective trial evaluating radiation-induced lymphocyte apoptosis and prostate RT. (April 2019)